Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases

The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially benefiting exchange traded funds, such as the SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) and...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.